CMFRI, Library (2022) CMFRI introduces nutraceutical from seaweed to combat fatty liver disease The New Indian Express dated 20th December 2022. The New Indian Express.
![[img]](https://eprints.cmfri.org.in/style/images/fileicons/text.png) |
Text
The New Indian Express_21-12-2022.pdf Download (94kB) |
Official URL: https://www.newindianexpress.com/lifestyle/health/...
Abstract
The CMFRI on Tuesday signed a Memorandum of Understanding (MoU) with Emineotech, a health products firm, for the commercial production and marketing of CadalminTM LivCure extract. CMFRI director A Gopalakrishnan signed a license agreement with Emineotech's managing director Evanjalist Pathrose for commercial production of the product.
| Item Type: | Article |
|---|---|
| Subjects: | CMFRI News Clippings |
| Divisions: | Library and Documentation Centre |
| Depositing User: | Mr. Augustine Sipson N A |
| Date Deposited: | 26 Dec 2022 04:31 |
| Last Modified: | 26 Dec 2022 04:31 |
| URI: | http://eprints.cmfri.org.in/id/eprint/16552 |
Actions (login required)
 |
View Item |
